Literature DB >> 9935192

Hepatocellular carcinoma in an orthotopic mouse model metastasizes intrahepatically in cirrhotic but not in normal liver.

S Kuriyama1, M Yamazaki, A Mitoro, T Tsujimoto, M Kikukawa, H Tsujinoue, T Nakatani, Y Toyokawa, H Yoshiji, H Fukui.   

Abstract

Prognosis of hepatocellular carcinoma (HCC) still remains poor mainly because of intrahepatic metastasis. In the majority of cases, HCC is found in conjunction with liver cirrhosis. It is, therefore, of great importance to investigate the invasive and metastatic behavior of HCC in cirrhotic liver. To examine this, a liver cirrhosis model was produced by injecting thioacetamide i.p. into mice. Murine HCC cells were labeled with the fluorescent carbocyanine dye, DiI, and implanted directly under the capsule of cirrhotic and normal livers of syngeneic mice. DiI-labeled HCC cells in the liver were observed under fluorescent and confocal microscopy. Histological analysis of cirrhotic and normal livers revealed that implanted HCC cells migrated to and invaded the adjacent periportal regions, but not the adjacent centrolobular areas. This characteristic behavior of HCC was more evident in cirrhotic liver than in normal liver. Furthermore, intrahepatic metastasis to unimplanted hepatic lobes was observed in cirrhotic liver as early as 7 days after implantation, while it was not detected in normal liver even 4 weeks later. Thus, an orthotopic animal model for HCC with cirrhosis described here may be suitable for investigating the invasive and metastatic behavior of HCC. Importantly, labeling tumor cells with a fluorescent dye before orthotopic implantation may be a convenient and useful method to investigate the invasive and metastatic behavior of various types of cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9935192     DOI: 10.1002/(sici)1097-0215(19990129)80:3<471::aid-ijc22>3.0.co;2-4

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Cytoglobin exhibits anti-fibrosis activity on liver in vivo and in vitro.

Authors:  Xin He; Ruoyun Lv; Ke Wang; Xiaofeng Huang; Wutong Wu; Lifang Yin; Yu Liu
Journal:  Protein J       Date:  2011-10       Impact factor: 2.371

Review 2.  Stimuli-induced organ-specific injury enhancement of organotropic metastasis in a spatiotemporal regulation.

Authors:  Dongwei Gao; Sha Li
Journal:  Pathol Oncol Res       Date:  2013-12-20       Impact factor: 3.201

3.  Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.

Authors:  Jörg Schrader; Timothy T Gordon-Walker; Rebecca L Aucott; Mariëlle van Deemter; Alexander Quaas; Shaun Walsh; Daniel Benten; Stuart J Forbes; Rebecca G Wells; John P Iredale
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

4.  Hepatic stellate cells secretes type I collagen to trigger epithelial mesenchymal transition of hepatoma cells.

Authors:  Ming-Chen Yang; Chih-Jung Wang; Pao-Chi Liao; Chia-Jui Yen; Yan-Shen Shan
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

5.  Experimental liver metastasis: standards for local cell implantation to study isolated tumor growth in mice.

Authors:  Otto Kollmar; Martin K Schilling; Michael D Menger
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  Antifibrotic properties of transarterial oncolytic VSV therapy for hepatocellular carcinoma in rats with thioacetamide-induced liver fibrosis.

Authors:  Jennifer Altomonte; Sabrina Marozin; Enrico N De Toni; Antonia Rizzani; Irene Esposito; Katja Steiger; Annette Feuchtinger; Claus Hellerbrand; Roland M Schmid; Oliver Ebert
Journal:  Mol Ther       Date:  2013-08-13       Impact factor: 11.454

7.  1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosis.

Authors:  Miroslaw Kornek; Veronika Lukacs-Kornek; Andreas Limmer; Esther Raskopf; Ursula Becker; Maren Klöckner; Tilman Sauerbruch; Volker Schmitz
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

8.  Sparse logistic regression for diagnosis of liver fibrosis in rat by using SCAD-penalized likelihood.

Authors:  Fang-Rong Yan; Jin-Guan Lin; Yu Liu
Journal:  J Biomed Biotechnol       Date:  2011-06-01

9.  Therapeutic and analysis model of intrahepatic metastasis reflects clinical behavior of hepatocellular carcinoma.

Authors:  Shigeaki Sawada; Koji Murakami; Takeshi Yamaura; Noriyasu Mitani; Kazuhiro Tsukada; Ikuo Saiki
Journal:  Jpn J Cancer Res       Date:  2002-02

10.  Establishment of rat liver cancer cell lines with different metastatic potential.

Authors:  Lei Song; Jian-Gang Zhang; Long Zheng; Xu Feng; Jie Hou; Huan-Ling Zhang; Shu-Feng Liu
Journal:  Sci Rep       Date:  2020-05-20       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.